mi pharma ltd

Live EstablishedSmall

mi pharma ltd Company Information

Share MI PHARMA LTD

Company Number

08341095

Directors

Krishna Patel

Shareholders

krishna k. patel

Group Structure

View All

Industry

Dispensing chemist in specialised stores

 

Registered Address

114-116 goodmayes road, ilford, IG3 9UZ

mi pharma ltd Estimated Valuation

£943.6k

Pomanda estimates the enterprise value of MI PHARMA LTD at £943.6k based on a Turnover of £2.7m and 0.36x industry multiple (adjusted for size and gross margin).

mi pharma ltd Estimated Valuation

£589.1k

Pomanda estimates the enterprise value of MI PHARMA LTD at £589.1k based on an EBITDA of £134.6k and a 4.38x industry multiple (adjusted for size and gross margin).

mi pharma ltd Estimated Valuation

£486.4k

Pomanda estimates the enterprise value of MI PHARMA LTD at £486.4k based on Net Assets of £217k and 2.24x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Mi Pharma Ltd Overview

Mi Pharma Ltd is a live company located in ilford, IG3 9UZ with a Companies House number of 08341095. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in December 2012, it's largest shareholder is krishna k. patel with a 100% stake. Mi Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £2.7m with unknown growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Mi Pharma Ltd Health Check

Pomanda's financial health check has awarded Mi Pharma Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

2 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £2.7m, make it smaller than the average company (£13.5m)

£2.7m - Mi Pharma Ltd

£13.5m - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Mi Pharma Ltd

- - Industry AVG

production

Production

with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)

32.4% - Mi Pharma Ltd

32.4% - Industry AVG

profitability

Profitability

an operating margin of 5.1% make it more profitable than the average company (2.7%)

5.1% - Mi Pharma Ltd

2.7% - Industry AVG

employees

Employees

with 18 employees, this is below the industry average (75)

18 - Mi Pharma Ltd

75 - Industry AVG

paystructure

Pay Structure

on an average salary of £29.2k, the company has an equivalent pay structure (£29.2k)

£29.2k - Mi Pharma Ltd

£29.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £147.5k, this is equally as efficient (£150.4k)

£147.5k - Mi Pharma Ltd

£150.4k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Mi Pharma Ltd

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 133 days, this is slower than average (60 days)

133 days - Mi Pharma Ltd

60 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Mi Pharma Ltd

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (14 weeks)

0 weeks - Mi Pharma Ltd

14 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 87.6%, this is a higher level of debt than the average (59.5%)

87.6% - Mi Pharma Ltd

59.5% - Industry AVG

MI PHARMA LTD financials

EXPORTms excel logo

Mi Pharma Ltd's latest turnover from December 2023 is estimated at £2.7 million and the company has net assets of £217 thousand. According to their latest financial statements, we estimate that Mi Pharma Ltd has 18 employees and maintains cash reserves of £19.1 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Turnover2,655,2322,506,62000000120,643062,45956,886
Other Income Or Grants00000000000
Cost Of Sales1,794,9341,666,6200000081,369043,45639,227
Gross Profit860,298840,0000000039,274019,00417,659
Admin Expenses725,713710,689-101,309-100,757-100,097-68,285-71,762-10,7617,44310,98515,921
Operating Profit134,585129,311101,309100,757100,09768,28571,76250,035-7,4438,0191,738
Interest Payable65,37568,90549,99253,31563,79668,41370,31234,880000
Interest Receivable86535433178212812617339218983
Pre-Tax Profit70,07560,75951,34947,45936,38401,57515,328-7,0518,2081,821
Tax-17,519-11,544-9,756-9,017-6,9130-299-3,0650-1,724-419
Profit After Tax52,55649,21541,59338,44229,47101,27612,262-7,0516,4841,402
Dividends Paid00000000000
Retained Profit52,55649,21541,59338,44229,47101,27612,262-7,0516,4841,402
Employee Costs526,025441,5130000018,590017,44217,415
Number Of Employees1817000001011
EBITDA*134,585129,311101,309100,757100,09768,28571,76250,035-7,4438,0191,738

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Tangible Assets00000000000
Intangible Assets00000000000
Investments & Other1,723,6351,723,6351,723,6351,723,6351,723,6351,723,6351,723,6351,723,635000
Debtors (Due After 1 year)00000000000
Total Fixed Assets1,723,6351,723,6351,723,6351,723,6351,723,6351,723,6351,723,6351,723,635000
Stock & work in progress00000000000
Trade Debtors0000000001,1641,397
Group Debtors00000000000
Misc Debtors000000025,726000
Cash19,07513,8886,34019,66414,2497,66926,58223,848114,51942,33633,128
misc current assets0000003,7880000
total current assets19,07513,8886,34019,66414,2497,66930,37049,574114,51943,50034,525
total assets1,742,7101,737,5231,729,9751,743,2991,737,8841,731,3041,754,0051,773,209114,51943,50034,525
Bank overdraft106,02092,22092,22092,23295,38895,38891,20068,485000
Bank loan00000000000
Trade Creditors 654,846664,842000000035,51433,023
Group/Directors Accounts00846,970826,823787,237741,119689,102640,659106,84800
other short term finances00000000000
hp & lease commitments00000000000
other current liabilities247,048219,7485,5495,2494,9484,6473,1493,1786,73600
total current liabilities1,007,914976,810944,739924,304887,573841,154783,451712,322113,58435,51433,023
loans367,758596,231669,969745,321815,079884,389956,0811,047,690000
hp & lease commitments00000000000
Accruals and Deferred Income00000000000
other liabilities150,0000000000000
provisions00000000000
total long term liabilities517,758596,231669,969745,321815,079884,389956,0811,047,690000
total liabilities1,525,6721,573,0411,614,7081,669,6251,702,6521,725,5431,739,5321,760,012113,58435,51433,023
net assets217,038164,482115,26773,67435,2325,76114,47313,1979357,9861,502
total shareholders funds217,038164,482115,26773,67435,2325,76114,47313,1979357,9861,502
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013
Operating Activities
Operating Profit134,585129,311101,309100,757100,09768,28571,76250,035-7,4438,0191,738
Depreciation00000000000
Amortisation00000000000
Tax-17,519-11,544-9,756-9,017-6,9130-299-3,0650-1,724-419
Stock00000000000
Debtors000000-25,72625,726-1,164-2331,397
Creditors-9,996664,842000000-35,5142,49133,023
Accruals and Deferred Income27,300214,1993003013011,498-29-3,5586,73600
Deferred Taxes & Provisions00000000000
Cash flow from operations134,370996,80891,85392,04193,48569,78397,16017,686-35,0579,01932,945
Investing Activities
capital expenditure00000000000
Change in Investments00000001,723,635000
cash flow from investments0000000-1,723,635000
Financing Activities
Bank loans00000000000
Group/Directors Accounts0-846,97020,14739,58646,11852,01748,443533,811106,84800
Other Short Term Loans 00000000000
Long term loans-228,473-73,738-75,352-69,758-69,310-71,692-91,6091,047,690000
Hire Purchase and Lease Commitments00000000000
other long term liabilities150,0000000000000
share issue00000-8,7120000100
interest-64,510-68,551-49,959-53,298-63,714-68,285-70,186-34,70739218983
cash flow from financing-142,983-989,259-105,164-83,470-86,906-96,672-113,3521,546,794107,240189183
cash and cash equivalents
cash5,1877,548-13,3245,4156,580-18,9132,734-90,67172,1839,20833,128
overdraft13,8000-12-3,15604,18822,71568,485000
change in cash-8,6137,548-13,3128,5716,580-23,101-19,981-159,15672,1839,20833,128

mi pharma ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for mi pharma ltd. Get real-time insights into mi pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Mi Pharma Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for mi pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in IG3 area or any other competitors across 12 key performance metrics.

mi pharma ltd Ownership

MI PHARMA LTD group structure

Mi Pharma Ltd has 1 subsidiary company.

Ultimate parent company

MI PHARMA LTD

08341095

1 subsidiary

MI PHARMA LTD Shareholders

krishna k. patel 100%

mi pharma ltd directors

Mi Pharma Ltd currently has 1 director, Mrs Krishna Patel serving since Dec 2012.

officercountryagestartendrole
Mrs Krishna PatelEngland38 years Dec 2012- Director

P&L

December 2023

turnover

2.7m

+6%

operating profit

134.6k

0%

gross margin

32.5%

-3.32%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

217k

+0.32%

total assets

1.7m

0%

cash

19.1k

+0.37%

net assets

Total assets minus all liabilities

mi pharma ltd company details

company number

08341095

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

December 2012

age

13

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

December 2023

previous names

N/A

accountant

ASHFORDS PARTNERSHIP LLP

auditor

-

address

114-116 goodmayes road, ilford, IG3 9UZ

Bank

-

Legal Advisor

-

mi pharma ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to mi pharma ltd.

mi pharma ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MI PHARMA LTD. This can take several minutes, an email will notify you when this has completed.

mi pharma ltd Companies House Filings - See Documents

datedescriptionview/download